Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

New Stable Isotope Method to Determine Protein Requirements in Critically Ill Children
Development of New Stable Isotope Method to Determine Protein Requirements in Critically Ill Children
Status: Enrolling
Updated:  10/10/2017
Arkansas Children's Hospital
mi
from
Little Rock, AR
New Stable Isotope Method to Determine Protein Requirements in Critically Ill Children
Development of New Stable Isotope Method to Determine Protein Requirements in Critically Ill Children
Status: Enrolling
Updated: 10/10/2017
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Efficacy of Recombinant Human Clara Cell Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Status: Enrolling
Updated:  10/11/2017
Tufts Medical Center
mi
from
Boston, MA
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Efficacy of Recombinant Human Clara Cell Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Status: Enrolling
Updated: 10/11/2017
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Efficacy of Recombinant Human Clara Cell Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Status: Enrolling
Updated:  10/11/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Efficacy of Recombinant Human Clara Cell Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Status: Enrolling
Updated: 10/11/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Efficacy of Recombinant Human Clara Cell Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Status: Enrolling
Updated:  10/11/2017
Baystate Medical Center
mi
from
Springfield, MA
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Efficacy of Recombinant Human Clara Cell Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Status: Enrolling
Updated: 10/11/2017
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Testing the Effectiveness of Telephone-based Early Childhood Developmental Screening
Developing and Testing a New Model for Telephone-based Early Childhood Developmental Screening and Care Coordination in Vulnerable Populations
Status: Enrolling
Updated:  10/11/2017
Clinica Oscar A Romero
mi
from
Los Angeles, CA
Testing the Effectiveness of Telephone-based Early Childhood Developmental Screening
Developing and Testing a New Model for Telephone-based Early Childhood Developmental Screening and Care Coordination in Vulnerable Populations
Status: Enrolling
Updated: 10/11/2017
Clinica Oscar A Romero
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Exercise to Reduce Obesity in Spinal Cord Injury
Exercise to Reduce Obesity in Spinal Cord Injury
Status: Enrolling
Updated:  10/13/2017
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Exercise to Reduce Obesity in Spinal Cord Injury
Exercise to Reduce Obesity in Spinal Cord Injury
Status: Enrolling
Updated: 10/13/2017
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator
Hemodynamic Instability Rules Based Advisor: The Impact to Care With a New Predictive Indicator (HIRBA 2.0)
Status: Enrolling
Updated:  10/13/2017
Alpert Medical School of Brown University, Rhode Island Hospital, Medical Intensive Care Unit
mi
from
Providence, RI
Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator
Hemodynamic Instability Rules Based Advisor: The Impact to Care With a New Predictive Indicator (HIRBA 2.0)
Status: Enrolling
Updated: 10/13/2017
Alpert Medical School of Brown University, Rhode Island Hospital, Medical Intensive Care Unit
mi
from
Providence, RI
Click here to add this to my saved trials
Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator
Hemodynamic Instability Rules Based Advisor: The Impact to Care With a New Predictive Indicator (HIRBA 2.0)
Status: Enrolling
Updated:  10/13/2017
Washington University in St. Louis School of Medicine, Department of Surgery, Section of Acute and Critical Care Surgery
mi
from
Saint Louis, MO
Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator
Hemodynamic Instability Rules Based Advisor: The Impact to Care With a New Predictive Indicator (HIRBA 2.0)
Status: Enrolling
Updated: 10/13/2017
Washington University in St. Louis School of Medicine, Department of Surgery, Section of Acute and Critical Care Surgery
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)
Applying Health Mechanics to Enhance Bowel and Bladder Health for Persons With SCI
Status: Enrolling
Updated:  10/13/2017
University of Michigan Spinal Cord Injury Model System
mi
from
Ann Arbor, MI
Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)
Applying Health Mechanics to Enhance Bowel and Bladder Health for Persons With SCI
Status: Enrolling
Updated: 10/13/2017
University of Michigan Spinal Cord Injury Model System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Fitbit for Postoperative Ambulation
Can a Fitbit (a Mobile Tracking Device) Increase Ambulation of Colorectal Surgical Patients in the Postoperative Period?
Status: Enrolling
Updated:  10/13/2017
Emory University Hospital
mi
from
Atlanta, GA
Fitbit for Postoperative Ambulation
Can a Fitbit (a Mobile Tracking Device) Increase Ambulation of Colorectal Surgical Patients in the Postoperative Period?
Status: Enrolling
Updated: 10/13/2017
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated:  10/13/2017
Cooper Univeristy Hospital
mi
from
Camden, NJ
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated: 10/13/2017
Cooper Univeristy Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health in Spinal Cord Injury
Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health in Spinal Cord Injury
Status: Enrolling
Updated:  10/16/2017
Kessler Foundation Research Center
mi
from
West Orange, NJ
Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health in Spinal Cord Injury
Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health in Spinal Cord Injury
Status: Enrolling
Updated: 10/16/2017
Kessler Foundation Research Center
mi
from
West Orange, NJ
Click here to add this to my saved trials
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated:  10/16/2017
Washington Hospital Center
mi
from
Washington, D.C.,
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated: 10/16/2017
Washington Hospital Center
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated:  10/16/2017
North Carolina Jaycee Burn Center
mi
from
Chapel Hill, NC
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated: 10/16/2017
North Carolina Jaycee Burn Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated:  10/16/2017
Wake Forest University Baptist
mi
from
Wake Forest, NC
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated: 10/16/2017
Wake Forest University Baptist
mi
from
Wake Forest, NC
Click here to add this to my saved trials
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated:  10/16/2017
Crozer-Chester Medical Center
mi
from
Upland, PA
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated: 10/16/2017
Crozer-Chester Medical Center
mi
from
Upland, PA
Click here to add this to my saved trials
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated:  10/17/2017
GSK Investigational Site
mi
from
Durham, NC
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated: 10/17/2017
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated:  10/17/2017
GSK Investigational Site
mi
from
Philadelphia, PA
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated: 10/17/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated:  10/17/2017
GSK Investigational Site
mi
from
Lexington, KY
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated: 10/17/2017
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated:  10/17/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated: 10/17/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated:  10/17/2017
GSK Investigational Site
mi
from
Pittsburgh, PA
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated: 10/17/2017
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated:  10/17/2017
GSK Investigational Site
mi
from
Nashville, TN
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Assessment of the Anti-Inflammatory Activity, Efficacy and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Status: Enrolling
Updated: 10/17/2017
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated:  10/17/2017
Cooper University Hospital
mi
from
Camden, NJ
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated: 10/17/2017
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated:  10/17/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated: 10/17/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated:  10/17/2017
St. Luke's Hospital
mi
from
Bethlehem, PA
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated: 10/17/2017
St. Luke's Hospital
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated:  10/17/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated: 10/17/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated:  10/17/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)
Status: Enrolling
Updated: 10/17/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Status: Enrolling
Updated:  10/18/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Status: Enrolling
Updated: 10/18/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Training in Goal-directed Attention Regulation for Individuals With Brain Injury
Plasticity in Brain Network to Enhance Cognitive Rehabilitation
Status: Enrolling
Updated:  10/18/2017
VA Northern California Health Care System, Mather, CA
mi
from
Sacramento, CA
Training in Goal-directed Attention Regulation for Individuals With Brain Injury
Plasticity in Brain Network to Enhance Cognitive Rehabilitation
Status: Enrolling
Updated: 10/18/2017
VA Northern California Health Care System, Mather, CA
mi
from
Sacramento, CA
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Providence Hospital,
mi
from
Mobile, AL
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Providence Hospital,
mi
from
Mobile, AL
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Community Regional Medical Center of Fresno
mi
from
Fresno, CA
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Community Regional Medical Center of Fresno
mi
from
Fresno, CA
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
UC Davis Medical Center
mi
from
Sacramento, CA
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
University of Iowa
mi
from
Iowa City, IA
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
ARH Regional Medical Center
mi
from
Hazard, KY
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
ARH Regional Medical Center
mi
from
Hazard, KY
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
University of Louisville Hospital Laboratory
mi
from
Louisville, KY
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
University of Louisville Hospital Laboratory
mi
from
Louisville, KY
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Lahey Hospital and Medical Center
mi
from
Burlington, MA
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Lahey Hospital and Medical Center
mi
from
Burlington, MA
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Baystate Medical Center
mi
from
Springfield, MA
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
University of Michigan Health Center
mi
from
Ann Arbor, MI
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
University of Michigan Health Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Henry Ford Hospital
mi
from
Detroit, MI
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Mayo Clinic Labs - Rochester Campus
mi
from
Rochester, MN
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Mayo Clinic Labs - Rochester Campus
mi
from
Rochester, MN
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
St. Patrick Hospital
mi
from
Missoula, MT
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
St. Patrick Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Cooper University Hospital
mi
from
Camden, NJ
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
New York Methodist Hospital
mi
from
Brooklyn, NY
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
New York Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
UNC Chapel Hill
mi
from
CHapel Hill, NC
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Mercy St. Vincent Medical Center, Clinical Research Offices
mi
from
Toledo, OH
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Mercy St. Vincent Medical Center, Clinical Research Offices
mi
from
Toledo, OH
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
OU Medical Center
mi
from
Oklahoma City, OK
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
OU Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated:  10/18/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)
Status: Enrolling
Updated: 10/18/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials